Home90B • FRA
add
Sophia Genetics SA
Previous close
€2.70
Day range
€2.60 - €2.60
Year range
€2.36 - €5.00
Market cap
203.17M USD
Avg Volume
27.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 17.78M | 12.68% |
Operating expense | 28.24M | -3.14% |
Net income | -17.38M | -26.86% |
Net profit margin | -97.78 | -12.58% |
Earnings per share | -0.18 | -31.57% |
EBITDA | -13.74M | 21.15% |
Effective tax rate | -2.98% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 68.53M | -33.94% |
Total assets | 146.72M | -18.61% |
Total liabilities | 61.11M | 27.24% |
Total equity | 85.61M | — |
Shares outstanding | 66.87M | — |
Price to book | 2.11 | — |
Return on assets | -26.55% | — |
Return on capital | -33.10% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -17.38M | -26.86% |
Cash from operations | -10.75M | 22.32% |
Cash from investing | -1.04M | 46.94% |
Cash from financing | -990.00K | -66.11% |
Net change in cash | -11.70M | 40.06% |
Free cash flow | -9.93M | -2.29% |
About
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France. It provides genomic and radiomic, and multimodal analysis for hospitals, laboratories, and biopharma institutions. Wikipedia
Founded
Jan 1, 2011
Website
Employees
423